Satoshi Shuto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Satoshi Shuto has a total of 362 co-authors. Here are the top co-authors by number of shared publications:
- Mitsuhiro Arisawa
Graduate School of Pharmaceutical Sciences, The University of Osaka, Yamada-oka 1-6, Suita, Osaka 565-0871, Japan
31 shared publications Hayato Fukuda
Department of Pharmaceutical Organic Chemistry, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8521, Japan
21 shared publicationsAkira Matsuda
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
19 shared publications- Mizuki Watanabe
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan
17 shared publications Hiroshi Abe
Graduate School of Sciences, Nagoya University , Nagoya , Japan
11 shared publicationsMizuki Watanabe
Laboratory of Organic Chemistry for Drug Development, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan
11 shared publications
Latest Publications
- 16 February 2026
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 183, 107064
Resolvin E1 and Resolvin E2 suppress cyclooxygenase-2 expression through ubiquitin-proteasome-mediated degradation in human macrophage-like U937 cells
- 16 February 2026
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 183, 107064
Resolvin E1 and Resolvin E2 suppress cyclooxygenase-2 expression through ubiquitin-proteasome-mediated degradation in human macrophage-like U937 cells
- 19 December 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 91 (1) , 466-476
Design and Synthesis of Cyclopropane Congeners of Resolvin E2 with Azidopropoxy Chain toward a Chemical Tool for Probing the Anti-inflammatory Activity
Resolvins (Rvs), unsaturated fatty acid metabolites are a new type of anti-inflammatory lipid mediator that promotes inflammation resolution, so that these compounds can be efficient leads for developing new anti-inflammatory drugs. We have previously developed a cyclopropane (CP) congener of resolving E2 (RvE2), i.e., CP-RvE2, as a stable equivalent of RvE2. In this study, based on the stable equivalent of CP-RvE2, we designed and synthesized AP-β-CP-RvE2, in which an azidopropoxy (AP) group was introduced into the 5-, 18-, or 20-position of CP-RvE2, as potential chemical probes. We found that among them, 5-AP-β-CP-RvE2 had anti-inflammatory activity same as RvE2, suggesting its potential utility as a chemical probe.
- 19 December 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 91 (1) , 466-476
Design and Synthesis of Cyclopropane Congeners of Resolvin E2 with Azidopropoxy Chain toward a Chemical Tool for Probing the Anti-inflammatory Activity
Resolvins (Rvs), unsaturated fatty acid metabolites are a new type of anti-inflammatory lipid mediator that promotes inflammation resolution, so that these compounds can be efficient leads for developing new anti-inflammatory drugs. We have previously developed a cyclopropane (CP) congener of resolving E2 (RvE2), i.e., CP-RvE2, as a stable equivalent of RvE2. In this study, based on the stable equivalent of CP-RvE2, we designed and synthesized AP-β-CP-RvE2, in which an azidopropoxy (AP) group was introduced into the 5-, 18-, or 20-position of CP-RvE2, as potential chemical probes. We found that among them, 5-AP-β-CP-RvE2 had anti-inflammatory activity same as RvE2, suggesting its potential utility as a chemical probe.
- 13 March 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (11) , 2677-2681
Highly Z-Selective Julia–Kocienski Olefination Using N-Sulfonylimines and Its Mechanistic Insights from DFT Calculations
The Julia-Kocienski (JK) olefination is effective for E-selective olefination, but highly Z-selective versions remain rare. Here, we report a highly Z-selective JK olefination (Z ratio >99:1) using N-sulfonylimines as electrophiles instead of aldehydes. This method demonstrates a broad substrate scope, tolerating electron-donating and -withdrawing groups, amides, halogens, carboxylic acids, and hydroxyls. Z-selectivity in our system arises from both the 1,2-addition and Smiles rearrangement steps without involving synperiplanar elimination. This study expands the toolkit for Z-selective olefin synthesis.
- 13 March 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (11) , 2677-2681
Highly Z-Selective Julia–Kocienski Olefination Using N-Sulfonylimines and Its Mechanistic Insights from DFT Calculations
The Julia-Kocienski (JK) olefination is effective for E-selective olefination, but highly Z-selective versions remain rare. Here, we report a highly Z-selective JK olefination (Z ratio >99:1) using N-sulfonylimines as electrophiles instead of aldehydes. This method demonstrates a broad substrate scope, tolerating electron-donating and -withdrawing groups, amides, halogens, carboxylic acids, and hydroxyls. Z-selectivity in our system arises from both the 1,2-addition and Smiles rearrangement steps without involving synperiplanar elimination. This study expands the toolkit for Z-selective olefin synthesis.
- Open Access
- 22 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Highly Z-selective Julia–Kocienski Olefination Using N-sulfonylimines and Its Mechanistic Insights from DFT Calculations
The Julia–Kocienski (JK) olefination is a powerful and widely used method for alkene synthesis, particularly favoring E-selective olefination. However, highly Z-selective variants remain underexplored. In this study, we report a highly Z-selective JK olefination (Z ratio >99:1) using N-sulfonylimines as electrophilic partners instead of traditional aldehydes. This approach exhibits broad substrate compatibility, accommodating a variety of sulfones and N-sulfonylimines with functional groups such as electron-donating and electron-withdrawing substituents, amides, halogens, carboxylic acids, and hydroxyls. The reaction enables efficient synthesis of valuable Z-alkenes, including (Z)-α,β-unsaturated amides, Z-alkenyl halides, and Z-trisubstituted alkenes, under mild and general conditions. Mechanistic investigations using DFT calculations revealed that Z-selectivity is established during the 1,2-addition step, contrasting with conventional Z-selective JK olefination, where the Smiles rearrangement step governs selectivity. This study not only expands the synthetic arsenal for stereoselective olefin synthesis but also provides a versatile and general method for constructing Z-olefins with high precision and efficiency.
- 22 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessHighly Z-selective Julia–Kocienski Olefination Using N-sulfonylimines and Its Mechanistic Insights from DFT Calculations
The Julia–Kocienski (JK) olefination is a powerful and widely used method for alkene synthesis, particularly favoring E-selective olefination. However, highly Z-selective variants remain underexplored. In this study, we report a highly Z-selective JK olefination (Z ratio >99:1) using N-sulfonylimines as electrophilic partners instead of traditional aldehydes. This approach exhibits broad substrate compatibility, accommodating a variety of sulfones and N-sulfonylimines with functional groups such as electron-donating and electron-withdrawing substituents, amides, halogens, carboxylic acids, and hydroxyls. The reaction enables efficient synthesis of valuable Z-alkenes, including (Z)-α,β-unsaturated amides, Z-alkenyl halides, and Z-trisubstituted alkenes, under mild and general conditions. Mechanistic investigations using DFT calculations revealed that Z-selectivity is established during the 1,2-addition step, contrasting with conventional Z-selective JK olefination, where the Smiles rearrangement step governs selectivity. This study not only expands the synthetic arsenal for stereoselective olefin synthesis but also provides a versatile and general method for constructing Z-olefins with high precision and efficiency.
- 4 December 2023
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 14 (12) , 1807-1814
Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity
(+)-Negamycin, which is a dipeptide-like antibiotic containing a hydrazide structure, exhibits readthrough activity, resulting in the restoration of dystrophin in the mdx mouse model of Duchenne muscular dystrophy (DMD). In our previous structure-activity relationship study of negamycin, we found that its natural analogue 3-epi-deoxynegamycin (TCP-107), without antimicrobial activity, showed a higher readthrough activity than negamycin. In this study, we designed and synthesized cyclopropane-based conformationally restricted derivatives of TCP-107 and evaluated their readthrough activity in the cell-based reporter assay against a TGA-type mutation derived from DMD. As a result, a down-cis isomer, TCP-304, showed significant readthrough activity among the four isomers. Moreover, TCP-306, a derivative acylated by l-α-aminoundecanoic acid, possessed approximately 3 times higher activity than TCP-304. These down-cis derivatives showed dose-dependent readthrough activity and were effective for not only TGA but also TAG mutations. These results suggest that the conformational restriction of negamycin derivatives by the introduction of the cyclopropane ring is effective for an exhibition of potent readthrough activity.
- 4 December 2023
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 14 (12) , 1807-1814
Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity
(+)-Negamycin, which is a dipeptide-like antibiotic containing a hydrazide structure, exhibits readthrough activity, resulting in the restoration of dystrophin in the mdx mouse model of Duchenne muscular dystrophy (DMD). In our previous structure-activity relationship study of negamycin, we found that its natural analogue 3-epi-deoxynegamycin (TCP-107), without antimicrobial activity, showed a higher readthrough activity than negamycin. In this study, we designed and synthesized cyclopropane-based conformationally restricted derivatives of TCP-107 and evaluated their readthrough activity in the cell-based reporter assay against a TGA-type mutation derived from DMD. As a result, a down-cis isomer, TCP-304, showed significant readthrough activity among the four isomers. Moreover, TCP-306, a derivative acylated by l-α-aminoundecanoic acid, possessed approximately 3 times higher activity than TCP-304. These down-cis derivatives showed dose-dependent readthrough activity and were effective for not only TGA but also TAG mutations. These results suggest that the conformational restriction of negamycin derivatives by the introduction of the cyclopropane ring is effective for an exhibition of potent readthrough activity.
- 15 June 2023
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 168, 106759
Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation
- 15 June 2023
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 168, 106759
Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation
- 18 November 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (5) , 970-980
Helix-forming aliphatic homo-δ-peptide foldamers based on the conformational restriction effects of cyclopropane
This work reports the first aliphatic homo-δ-peptide helical foldamer consisting of a conformationally restricted δ-amino acid, where the structural characteristics of cyclopropane tightly control the backbone torsion angles.
- 18 November 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (5) , 970-980
Helix-forming aliphatic homo-δ-peptide foldamers based on the conformational restriction effects of cyclopropane
This work reports the first aliphatic homo-δ-peptide helical foldamer consisting of a conformationally restricted δ-amino acid, where the structural characteristics of cyclopropane tightly control the backbone torsion angles.
- 22 July 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (15) , 10501-10508
Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents
Resolvins are pro-resolving lipid mediators with highly potent anti-inflammatory effects. Because of their polyunsaturated structures, however, they are unstable to oxygen as a drug prototype. To address this issue, we designed and synthesized CP-RvE3 as oxidatively stable congeners of RvE3 by replacing the cis-olefin with a cis-cyclopropane to avoid the unstable bisallylic structure. Although the oxidative stabilities of CP-RvE3 were not improved, beta-CP-RvE3 was 3.7 times more metabolically stable than RvE3. Thus, we identified beta-CP-RvE3 as a metabolically stable equivalent.
- 22 July 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (15) , 10501-10508
Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents
Resolvins are pro-resolving lipid mediators with highly potent anti-inflammatory effects. Because of their polyunsaturated structures, however, they are unstable to oxygen as a drug prototype. To address this issue, we designed and synthesized CP-RvE3 as oxidatively stable congeners of RvE3 by replacing the cis-olefin with a cis-cyclopropane to avoid the unstable bisallylic structure. Although the oxidative stabilities of CP-RvE3 were not improved, beta-CP-RvE3 was 3.7 times more metabolically stable than RvE3. Thus, we identified beta-CP-RvE3 as a metabolically stable equivalent.
- 22 July 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 71, 116944
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b)
- 22 July 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 71, 116944
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b)
- 8 June 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 24 (23) , 4151-4154
Synthesis of γ-Aminobutyric Acid (GABA) Analogues Conformationally Restricted by Bicyclo[3.1.0]hexane/hexene or [4.1.0]Heptane/heptene Backbones as Potent Betaine/GABA Transporter Inhibitors
Novel γ-aminobutyric acid (GABA) analogues 3-5, having a bicyclo[3.1.0]hexene, [4.1.0]heptane, or [4.1.0]heptene backbone, respectively, were designed from the bioactive form analysis of the previous inhibitor 2 with a bicyclo[3.1.0]hexane backbone. Compounds 3-5 and 2 were synthesized from a common 1,7-diene intermediate 6 using ring-closing metathesis (RCM) to construct the key bicyclo backbones. Compounds 3-5 strongly inhibit betaine/GABA transporter 1 (BGT1) uptake, but compound 4 stands out with its selective low micromolar potency.
- 8 June 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 24 (23) , 4151-4154
Synthesis of γ-Aminobutyric Acid (GABA) Analogues Conformationally Restricted by Bicyclo[3.1.0]hexane/hexene or [4.1.0]Heptane/heptene Backbones as Potent Betaine/GABA Transporter Inhibitors
Novel γ-aminobutyric acid (GABA) analogues 3-5, having a bicyclo[3.1.0]hexene, [4.1.0]heptane, or [4.1.0]heptene backbone, respectively, were designed from the bioactive form analysis of the previous inhibitor 2 with a bicyclo[3.1.0]hexane backbone. Compounds 3-5 and 2 were synthesized from a common 1,7-diene intermediate 6 using ring-closing metathesis (RCM) to construct the key bicyclo backbones. Compounds 3-5 strongly inhibit betaine/GABA transporter 1 (BGT1) uptake, but compound 4 stands out with its selective low micromolar potency.